The <scp>C</scp>hronic <scp>K</scp>idney <scp>D</scp>isease <scp>E</scp>pidemiology <scp>C</scp>ollaboration cystatin <scp>C</scp> (<scp>CKD</scp>‐<scp>EPI</scp>‐<scp>C</scp>ys<scp>C</scp>) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from <scp>MDRD</scp> to <scp>CKD</scp>‐<scp>EPI</scp>‐<scp>C</scp>ys<scp>C</scp> equations?
Evangelos Terpos(National and Kapodistrian University of Athens), Efstathios Kastritis(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(Korea University), Eirini Katodritou(Evangelismos Hospital), Anastasia Pouli(Evangelismos Hospital), Dimitrios Christoulas(National and Kapodistrian University of Athens), Ioannis Papassotiriou(National and Kapodistrian University of Athens), Eurydiki Michalis(General Hospital of Athens G. Genimatas)
Cited by 46
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k